The U.S. gives a two-year, $4.7M contract to Cytori Therapeutics (CYTX) for a stem cell therapy...

|About: Cytori Therapeutics Inc (CYTX)|By:, SA News Editor

The U.S. gives a two-year, $4.7M contract to Cytori Therapeutics (CYTX) for a stem cell therapy to treat "burns caused by thermal or radioactive bombs." With key milestones, the deal could be worth $106M over five years, the company (with $10M in annual revenue) reports. CYTX +17.1% premarket.